{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:10Z","timestamp":1792098550404,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.canep.2019.101664","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T13:15:08Z","timestamp":1577366108000},"page":"101664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015"],"prefix":"10.1016","volume":"64","author":[{"given":"Sara J.","family":"Schonfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Berrington de Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle E.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari M.","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canep.2019.101664_bib0005","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1245\/s10434-011-2193-2","article-title":"Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study","volume":"19","author":"Lal","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2019.101664_bib0010","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2005-2009","article-title":"Second primary cancers in thyroid cancer patients: a multinational record linkage study","volume":"91","author":"Sandeep","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.canep.2019.101664_bib0015","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/ijc.24581","article-title":"Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer survivor Study","volume":"125","author":"Taylor","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","article-title":"Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study","volume":"21","author":"Veiga","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"11","key":"10.1016\/j.canep.2019.101664_bib0025","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1210\/jc.2015-1690","article-title":"Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood Cancer","volume":"100","author":"de Vathaire","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.canep.2019.101664_bib0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1667\/RR2240.1","article-title":"Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study","volume":"174","author":"Bhatti","year":"2010","journal-title":"Radiat. Res."},{"issue":"5","key":"10.1016\/j.canep.2019.101664_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1667\/RR14213.1","article-title":"Thyroid Cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies","volume":"185","author":"Veiga","year":"2016","journal-title":"Radiat. Res."},{"issue":"9503","key":"10.1016\/j.canep.2019.101664_bib0040","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.canep.2019.101664_bib0045","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of solid Cancer After treatment of testicular germ cell Cancer in the platinum era","volume":"36","author":"Groot","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2019.101664_bib0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2013.11.237","article-title":"Thyroid malignancies in survivors of Hodgkin lymphoma","volume":"88","author":"Michaelson","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.canep.2019.101664_bib0055","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/ijc.29667","article-title":"Radiotherapy did not increase thyroid cancer risk among women with breast cancer: a nationwide population-based cohort study","volume":"137","author":"Sun","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2019.101664_bib0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","article-title":"A Linkage Between Thyroid and Breast Cancer: A Common Etiology?","volume":"28","author":"Bolf","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"11","key":"10.1016\/j.canep.2019.101664_bib0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.canep.2019.101664_bib0070","series-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000","author":"Curtis","year":"2006"},{"key":"10.1016\/j.canep.2019.101664_bib0075","series-title":"Schottenfeld and Fraumeni: Cancer Epidemiology and Prevention","first-page":"839","article-title":"Chapter 44: thyroid cancer","author":"Kitahara","year":"2018"},{"key":"10.1016\/j.canep.2019.101664_bib0080","series-title":"SEER Cancer Statistics Review, 1975-2015","author":"Noone","year":"2017"},{"key":"10.1016\/j.canep.2019.101664_bib0085","series-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2000"},{"issue":"20","key":"10.1016\/j.canep.2019.101664_bib0090","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1182\/blood-2010-06-289561","article-title":"InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions","volume":"116","author":"Turner","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.canep.2019.101664_bib0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid Cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat. Res."},{"issue":"11","key":"10.1016\/j.canep.2019.101664_bib0105","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/aje\/kwg278","article-title":"A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers","volume":"158","author":"Yasui","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2019.101664_bib0110","series-title":"Epicure Risk Regression and Person-Year Computation Software: Command Summary and User Guide","author":"Preston","year":"2015"},{"issue":"2","key":"10.1016\/j.canep.2019.101664_bib0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.21064","article-title":"Thyroid cancer and multiple primary tumors in the SEER cancer registries","volume":"117","author":"Ronckers","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2019.101664_bib0120","series-title":"Schottenfeld and Fraumeni: Cancer Epidemiology and Prevention","first-page":"227","article-title":"Chapter 13: ionizing radiation","author":"Berrington de Gonzalez","year":"2018"},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23735","article-title":"Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome","volume":"111","author":"Mester","year":"2015","journal-title":"J. Surg. Oncol."},{"issue":"17","key":"10.1016\/j.canep.2019.101664_bib0130","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.2013.53.6656","article-title":"Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations","volume":"32","author":"Ngeow","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2019.101664_bib0135","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.2017-02599","article-title":"Benign thyroid diseases and risk of thyroid Cancer: a nationwide cohort study","volume":"103","author":"Kitahara","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.canep.2019.101664_bib0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study","volume":"174","author":"Sogaard","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.canep.2019.101664_bib0145","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"G. International Agency for Research on Cancer Handbook Working, Body Fatness and Cancer--Viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canep.2019.101664_bib0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1245\/s10434-012-2718-3","article-title":"Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies","volume":"20","author":"Van Fossen","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-016-9395-7","article-title":"Thyroid dysfunction and kidney disease: an update","volume":"18","author":"Iglesias","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.canep.2019.101664_bib0160","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/ajt.14310","article-title":"Risk of thyroid Cancer Among solid organ transplant recipients","volume":"17","author":"Kitahara","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"9173","key":"10.1016\/j.canep.2019.101664_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.canep.2019.101664_bib0170","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.canep.2019.101664_bib0175","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1245\/s10434-014-4066-y","article-title":"Coupling of prostate and thyroid cancer diagnoses in the United States","volume":"22","author":"Tomaszewski","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2019.101664_bib0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/thy.2011.0406","article-title":"The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas","volume":"23","author":"Kim","year":"2013","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.canep.2019.101664_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.29025","article-title":"Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea","volume":"121","author":"Cho","year":"2015","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.canep.2019.101664_bib0190","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","article-title":"Tobacco smoking and cancer: a brief review of recent epidemiological evidence","volume":"45","author":"Sasco","year":"2004","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.canep.2019.101664_bib0195","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41416-018-0224-5","article-title":"Cigarette smoking and thyroid cancer risk: a cohort study","volume":"119","author":"Cho","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"15","key":"10.1016\/j.canep.2019.101664_bib0200","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood-2011-02-337170","article-title":"Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study","volume":"118","author":"Nielsen","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ijc.22672","article-title":"Risk of second cancer after chronic lymphocytic leukemia","volume":"121","author":"Sch\u00f6llkopf","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.canep.2019.101664_bib0210","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjc.2011.313","article-title":"Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study","volume":"105","author":"Royle","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2019.101664_bib0215","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.29.1112","article-title":"Second malignancy risks after Non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype","author":"Morton","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canep.2019.101664_bib0220","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clml.2017.06.028","article-title":"Risk of second primary malignancies in patients with follicular lymphoma: a United States population-based study","volume":"17","author":"Giri","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.canep.2019.101664_bib0225","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1038\/bcj.2013.19","article-title":"Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics","volume":"3","author":"Razavi","year":"2013","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjh.14638","article-title":"Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era","volume":"178","author":"Tao","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canep.2019.101664_bib0235","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2504","article-title":"Lymphomas and thyroid: bridging the gap","author":"Mancuso","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canep.2019.101664_bib0240","series-title":"Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"issue":"7","key":"10.1016\/j.canep.2019.101664_bib0245","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls","volume":"98","author":"van den Brand","year":"2013","journal-title":"A systematic review, Haematologica"},{"issue":"1","key":"10.1016\/j.canep.2019.101664_bib0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/10428194.2018.1471600","article-title":"Location matters in early stage nodal diffuse large B-cell lymphoma","volume":"60","author":"Lontos","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"30","key":"10.1016\/j.canep.2019.101664_bib0255","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canep.2019.101664_bib0260","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Med. Care"},{"issue":"7","key":"10.1016\/j.canep.2019.101664_bib0265","first-page":"3855","article-title":"Second primary malignancies in adult acute myeloid leukemia--A US population-based study","volume":"34","author":"Ghimire","year":"2014","journal-title":"Anticancer Res."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:26:35Z","timestamp":1761801995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782119301742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"alternative-id":["S1877782119301742"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.101664","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.101664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101664"}}